Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life

In a previous study, 3-dose primary vaccination of Nigerian infants with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) was immunogenic for vaccine pneumococcal serotypes, with comparable tolerability between PHiD-CV and control groups. In an open...

Descripción completa

Detalles Bibliográficos
Autores principales: Odusanya, Olumuyiwa O, Kuyinu, Yetunde A, Kehinde, Omolara A, Shafi, Fakrudeen, François, Nancy, Yarzabal, Juan Pablo, Dobbelaere, Kurt, Rüggeberg, Jens U, Borys, Dorota, Schuerman, Lode
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130271/
https://www.ncbi.nlm.nih.gov/pubmed/24356787
http://dx.doi.org/10.4161/hv.27276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130271/
https://www.ncbi.nlm.nih.gov/pubmed/24356787
http://dx.doi.org/10.4161/hv.27276

Ejemplares similares